Jessica Hopfield, a director at Insulet Corp (PODD), sold PODD shares on the open market once in the last 365 days for a total of $1.66 million, with her most recent sale on May 13, 2025. Her sales rank 3,847th among 11,678 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 16, 2025 | MARAVAI LIFESCIENCES HOLDINGS, INC. | $MRVI | Hopfield Jessica | Director | A | Class A Common Stock | 89139 | $2.16 | 199,907.0000 | 137,906,000 | 80.47% | 0.06% |
| June 6, 2025 | Editas Medicine, Inc. | $EDIT | Hopfield Jessica | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| May 22, 2025 | INSULET CORP | $PODD | Hopfield Jessica | Director | A | Common Stock | 778 | $0.00 | 27,695.0000 | 73,890,000 | 2.89% | 0.00% |
| May 13, 2025 | INSULET CORP | $PODD | Hopfield Jessica | Director | M | Stock Option (Right to Buy) | 5235 | $0.00 | 0.0000 | 73,890,000 | 100.00% | 0.01% |
| May 13, 2025 | INSULET CORP | $PODD | Hopfield Jessica | Director | M | Common Stock | 5235 | $28.87 | 32,152.0000 | 73,890,000 | 19.45% | 0.01% |
| May 13, 2025 | INSULET CORP | $PODD | Hopfield Jessica | Director | S | Common Stock | 5235 | $317.54 | 26,917.0000 | 73,890,000 | 16.28% | 0.01% |
| Sept. 11, 2024 | INSULET CORP | $PODD | Hopfield Jessica | Director | M | Common Stock | 7628 | $29.87 | 34,545.0000 | 73,633,000 | 28.34% | 0.01% |
| Sept. 11, 2024 | INSULET CORP | $PODD | Hopfield Jessica | Director | S | Common Stock | 7628 | $225.26 | 26,917.0000 | 73,633,000 | 22.08% | 0.01% |
| Sept. 11, 2024 | INSULET CORP | $PODD | Hopfield Jessica | Director | M | Stock Option (Right to Buy) | 7628 | $0.00 | 0.0000 | 73,633,000 | 100.00% | 0.01% |
| May 30, 2024 | Editas Medicine, Inc. | $EDIT | Hopfield Jessica | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | MARAVAI LIFESCIENCES HOLDINGS, INC. | $MRVI | Hopfield Jessica | Director | A | Class A Common Stock | 20645 | $10.78 | 110,768.0000 | 131,919,000 | 22.91% | 0.02% |
| May 22, 2024 | INSULET CORP | $PODD | Hopfield Jessica | Director | A | Common Stock | 1380 | $0.00 | 26,917.0000 | 73,633,000 | 5.40% | 0.00% |
| May 13, 2024 | Editas Medicine, Inc. | $EDIT | Hopfield Jessica | Director | P | Common Stock | 45000 | $5.64 | 67,700.0000 | 0 | 198.24% | 0.00% |
| June 1, 2023 | Editas Medicine, Inc. | $EDIT | Hopfield Jessica | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2023 | INSULET CORP | $PODD | Hopfield Jessica | Director | A | Common Stock | 843 | $0.00 | 25,537.0000 | 69,910,000 | 3.41% | 0.00% |